Showing 2381-2390 of 7117 results for "".
Diversity and Inclusion in Dermatology: The Impact of Systemic Racism in Dermatology and Opportunities for Change
https://practicaldermatology.com/issues/supplements/diversity-and-inclusion-in-dermatology-the-impact-of-systemic-racism-in-dermatology-and-opportunities-for-change/23474/Wishful Thinking: Looking to the Year Ahead
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/wishful-thinking-looking-to-the-year-ahead/23435/Cosmetic Surgery Forum faculty share resolutions for 2021.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-17/23343/Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.Physician Spotlight With A. Yasmine Kirkorian, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-with-a-yasmine-kirkorian-md/23082/A Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.Harnessing the Power of Humor for Psoriasis
https://practicaldermatology.com/topics/psoriasis/harnessing-the-power-of-humor-for-psoriasis/23007/Humor can create positive changes in our thoughts, feelings, behaviors, and biochemistry and can also influence how patients cope.Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeBiosimilars: Generic Biologics or Something Much More Complex?
https://practicaldermatology.com/topics/practice-management/biosimilars-generic-biologics-or-something-much-more-complex/21013/The looming availability of biosimilar medications raises important clinical and regulatory questions.Managing Pruritus in Geriatric Patients
https://practicaldermatology.com/topics/practice-management/managing-pruritus-in-geriatric-patients/21146/Treatment tips and considerations for this patient population.